InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2021-11-02 00:00:00 ET · period of report 2021-10-25 · accession 0001209191-21-062551 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-02 2021-10-25 WGS Coffin James Pres, COO M - OptEx — +22.5K 22.5K New —
D 2021-11-02 2021-10-25 WGS Coffin James Pres, COO S - Sale+OE $7.54 -5,752 16.8K -26% -$43.4K
D 2021-11-02 2021-10-25 WGS Coffin James Pres, COO M - OptEx $0.00 -22.5K 337.8K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-10-25 M A 22,517 — 22,517 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2021-10-25 S D 5,752 $7.54 16,765 D — —
3 Derivative Restricted Stock Unit 2021-10-25 M D 22,517 $0.00 337,768 D — · — to — 22,517 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.